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Abstract
Colorectal cancer (CRC) is one of the most common cancers 
in the USA. In 2017, an estimated 135,420 people were 
diagnosed with CRC and 50,260 people died from CRC. 
Several screening modalities are recommended by the United 
States Preventive Services Task Force (USPSTF), including 
annual stool tests that are usually completed at home and 
under-used compared with colonoscopy despite stated patient 
preferences for an alternative to colonoscopy. The Community 
Preventive Services Task Force recommends use of small media 
interventions (SMIs) to increase CRC screening and calls for a 
greater understanding of its independent impact on screening 
participation. This study tested whether a SMI increased the 
likelihood of participant return of a USPSTF recommended 
Fecal Immunochemical Test (FIT). In total, 804 individuals 
participated in a two-group, prospective randomized controlled 
trial. Descriptive statistics with chi-square tests compared 
differences in participant characteristics and return rates. 
Multivariable log-binomial modeling estimated combined effects 
of patient characteristics with FIT return rates. No differences in 
return rates were observed overall or by participant character-
istics other than the year of enrollment. A multivariable model 
controlling for all covariates, found gender, insurance type, and 
regular place for healthcare to be significantly associated with 
return rates. Receipt of the SMI did not independently increase 
overall return rates but it may have improved the ease of com-
pleting the FIT by some participants, particularly women, those 
with insurance, and those with a regular place for healthcare.
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INTRODUCTION
Colorectal cancer (CRC) is one of the most com-
mon cancers in the USA. In 2017, it is estimated that 
135,420 people will be diagnosed with CRC, and 
50,260 people will die from it. CRC is disproportion-
ately burdensome for African-Americans (AAs) who 
experience 25% greater incidence and nearly 50% 
greater mortality compared with Caucasians [2]. This 
disparity is particularly striking given the substantial 
improvements in CRC incidence and declines in mor-
tality overall in the past 25 years, which are largely 
attributed to improvements in screening [1–3].
As this study was in its planning phase in 2008, 
the United States Preventive Services Task Force 
(USPSTF) released its third set of screening 
recommendations: colonoscopy every 10  years, 
annual Fecal Immunochemical Tests (FIT), annual 
high-sensitivity Fecal Occult Blood Tests (FOBT), 
or flexible sigmoidoscopy every 5 years combined 
with high-sensitivity FOBT every 3 years [4]. Each 
modality was found to have functionally equivalent 
effectiveness for early detection of CRC when used 
according to guidelines [4]. A new set of recommen-
dations was published in 2016 [5–7].
Use of effective screening modalities has been hin-
dered by many factors, including differential percep-
tions of the invasiveness, discomfort, convenience, 
privacy, and cost of each modality, as well as differen-
tial awareness of CRC risk and the benefits of screen-
ing [6, 8–11]. In addition to being the least costly and 
thus presenting the lowest financial barrier, several 
studies have shown that home-based stool tests (FIT, 
Implications
Practice: The use of small media interventions 
may help patients overcome individual, health-
care system, and other barriers to participation 
in colorectal cancer screening programs and 
encourage their use and return of home-based 
stool tests.
Policy: Low colorectal cancer screening rates 
among vulnerable populations may be improved 
by programs and services, including small media 
interventions that increase individual awareness 
of effective, cost efficient, home-based stool 
testing.
Research: Research to increase the participation 
of vulnerable populations in colorectal cancer 
screening should focus on multilevel, multimodal 
approaches to refine and promote the use of 
small media in combination with other proven 
approaches (e.g., use of patient navigators/com-
munity health educators) along with a choice of 
screening options, including newly developed, 
more sensitive/specific, and easier to use home-
based stool tests.
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FOBT) are preferred by patients for their perceived 
convenience and minimal invasiveness and discom-
fort, among other factors [10, 12–14]. However, the 
use of available home-based stool tests for CRC has 
been hampered by a lack of awareness of test avail-
ability and effectiveness, as well as low completion 
rates, especially in groups with low health literacy or 
cultural health beliefs that do not emphasize preven-
tion [10, 15–17].
Several approaches are recommended by the 
Community Preventive Services Task Force (Task 
Force) to increase participation in CRC screening 
[18, 19]. One approach is the use of small media inter-
ventions (SMI) that may include videos and printed 
materials such as letters, brochures, and newsletters 
to inform and motivate people to be screened for 
cancer. SMI can also provide information tailored 
to specific individuals or groups and may be distrib-
uted either directly or through community or health-
care settings [18]. The Task Force supports the use 
of SMI to increase screening and calls for research 
to examine the utility of small media to address 
structural and other barriers among specific popu-
lations, such as those who have never been screened 
or who may be difficult to reach regarding screen-
ing [20, 21]. This study responds to the Task Force 
call for additional small media research as a means 
to address “other barriers” faced by minority and 
underserved populations and tests whether partici-
pants receiving a SMI are more likely to return a FIT 
than those not receiving the SMI.
METHODS
A two-group, prospective randomized controlled 
trial (RCT) was implemented in eight primary care 
clinics in collaboration with four health organi-
zations in North Carolina (NC) and one in South 
Carolina (SC). Each clinical site serves or served 
(one NC clinic closed during the study) a broad 
population including AA and the uninsured and 
underinsured. Two clinics were in adjacent east-
ern NC counties (Edgecombe and Nash), a rural 
area of the state where approximately 50% of the 
148,000 residents are AA. Other NC clinics were 
in Guilford County, a more urban county in central 
North Carolina where 34% of the 515,000 residents 
are AA. Charleston, in southeast South Carolina, is 
a city in which 25% of the 132,000 residents are AA. 
These clinics focus on providing a range of afford-
able, high-quality care to members of their local and 
regional communities and whose incomes may fall 
below 225% of the federal poverty level.
The principal investigator held in-person meet-
ings with medical and administrative directors in 
each primary care clinic to present the opportunity 
to participate in the study and review the study 
aims and protocol. Once agreement to participate 
was reached, the PI worked with each clinic’s clin-
ical leads to tailor the protocol to avoid disruptions 
to patient flow and standard operating procedures. 
Research team members provided initial and ongo-
ing training on how to implement the protocol, 
shared data on participant recruitment numbers 
each month, and met, as needed to resolve any 
observed problems with recruitment, data collec-
tion, or other issues.
The study protocol was submitted to and approved 
by the UNC Institutional Review Board (IRB) or the 
IRB at the Medical University of South Carolina.
Participants
Potential study participants were identified via med-
ical record as English-speaking AA individuals over 
the age of 50 years and younger than 75 years seek-
ing care at one of the study sites. Prospective par-
ticipant recruitment occurred in one of three ways: 
(1) in-person with same-day enrollment; (2) in-per-
son recruitment with delayed enrollment; or (3) in
response to a mailed recruitment letter. Regardless
of the recruitment method, each participant was
interviewed by research staff using the Colorectal
Cancer Risk Survey Profile (CRCRSP) to deter-
mine if they met study eligibility criteria: average
risk of CRC (e.g., no personal or first-degree fam-
ily history of CRC), having no symptoms of CRC
(e.g., rectal bleeding), and not up-to-date on CRC
screening per 2008 USPSTF recommendations (no
FOBT or FIT CRC screening test in the past year,
no sigmoidoscopy or barium enema in the past
5 years, and no colonoscopy in the past 10 years).
All CRCRSP responses were entered directly into a
REDCap database by a research team member and
transferred to a secure server location at UNC via
daily upload.
Eligibility for the RCT was determined in real 
time using an algorithm embedded in REDCap. 
Individuals reporting symptoms of CRC or family 
history of CRC were immediately referred to their 
primary care provider for usual care follow-up. 
Eligible individuals willing to participate in the study 
provided written informed consent prior to enroll-
ment. A  computer algorithm randomly assigned 
eligible, consented participants to an intervention 
group. Across all sites, 2402 patients were screened, 
914 patients (38%) were eligible for the trial, and 804 
(88%) eligible patients were consented, enrolled, 
and randomized into two intervention groups (FIT-
SMI (n = 419, 52%) and FIT (n = 385, 48%)). The 
summarized cohort assembly is presented in Fig. 1.
Around month 20 of the enrollment period, a nota-
ble lag in enrollment was examined using the results 
of CRCRSP data from sites participating at the time 
(n = 2). A review of accrual data for each site showed 
that a higher percentage of potential participants 
reported being up-to-date on CRC screening in this 
study (67%) compared with those in the pilot study 
conducted between 2008 and 2010 (34%). Other eli-
gibility categories (family history, etc.) did not differ. 
Investigators reported these data and their concerns 
about being able to meet target enrollment to the 
funding agency. Investigators were advised to open 
additional study sites and relax eligibility criteria to 
allow all under or uninsured participants. Beginning 
in month 23, both recommended approaches were 
implemented as the study was initiated in two addi-
tional clinics and “patients other than AA race” was 
no longer an exclusion for eligibility.
INTERVENTION
The small-media intervention was developed from 
input received from two consecutive focus groups 
with AA women and men aged 50 years and older 
from communities that reflected the target patient 
population [22]. The goal of the first focus group 
was to elicit knowledge of and opinions about CRC 
and screening options in the AA community, infor-
mation on individual, healthcare and other systems 
barriers to participation in CRC screening, and 
attributes of effective messaging. The participants 
also reviewed and offered comments on the existing 
CRC screening tests available to them.
Based on feedback from focus group participants, 
the study team prepared two SMI prototypes with 
educational messages and materials designed to pro-
mote the benefit of early and periodic CRC screen-
ing as recommended by the USPSTF and to address 
information and logistical needs associated with 
completing a stool test at home. Each SMI contained 
items recommended by the first focus group: a large 
water-resistant envelope (“to keep everything in one 
place”) with colorful health messaging (“to remind 
me of why I need to do this test”), a frequently asked 
questions (FAQ) sheet with a toll-free number to 
call for help, a set of specific instructions with pho-
tographs of how to obtain a fecal sample, use of a 
large font (“so I don’t have to put on my glasses”), a 
stamped, self-addressed envelope to return the test 
cards (“so I don’t have to pay postage or go to the 
post office”), and a drying envelope to protect stool 
samples from contamination and/or prevent contact 
by others as the cards dried (“my grands get into 
everything”) [22]. Participants in the second focus 
group offered comments on the SMI prototypes and 
chose the SMI shown in Fig. 2 (FIT-SMI).
In each setting, providers were notified of partici-
pant eligibility for the study and asked to remind all 
eligible patients (i.e., those between ages of 50 and 
74, at low risk for CRC and not up-to-date on CRC 
screening) during their clinic visit that they were 
due for CRC screening and that options for screen-
ing were available to them (options varied by site, 
e.g., hospital sites were able to do colonoscopy on
site vs. free standing clinics which did not offer col-
onoscopy on site). Scripting beyond this advice for
providers was not provided as part of this study, in
part to not unduly influence an individual’s decision
to participate in a home-based stool test study.
Study participants received either the FIT (con-
trol) or the FIT-SMI (intervention). Participants 
in the FIT group received three stool collection 
cards, tissue paper and scoops for stool collection, 
and a stamped self-addressed envelope for return-
ing the stool collection cards. In addition to these 
items, the FIT-SMI group received the SMI which 
included a water-resistant envelope with colorful, 
large-font health messaging, a FAQ with toll-free 
Fig 1 | CONSORT flow diagram: participant enrollment and follow-up, small-media CRC screening trial, all sites, 2011–2016.
number to call for help, specific instructions and 
photos to inform stool collection, and a drying 
envelope.
Study participants in both intervention groups 
received all materials free of charge (test cards and 
return envelopes donated by Beckman Coulter) 
and were not charged a lab-processing fee. 
Follow-up expenses associated with a positive test 
were covered for all participants via the patient’s 
insurance and/or pro bono provision of services 
by hospitals affiliated with each clinic or by UNC 
Health Care system providers. Patients without 
insurance coverage were also referred to appro-
priate local services and resources for enrollment 
in available services, including Medicare and/or 
Medicaid. Coverage of financial costs for those 
without insurance was negotiated with local and 
state health providers prior to the start of the trial. 
Participants could either mail or return the FIT in 
person to the clinic.
A reminder was sent to each study participant by 
the USA mail if the FIT was not returned within 2 
weeks of distribution. FITs returned after 6 weeks 
from the date of receipt were counted as “not 
returned.”
OUTCOME MEASURE
The primary outcome of the study was the FIT 
return rate: the number of FITs returned by study 
participants compared with the number of FITs dis-
tributed to study participants.
STATISTICAL ANALYSIS
Using the O’Brien-Fleming method that allows for 
early stopping of the trial if a larger or smaller than 
expected difference in return rates was observed 
after half of the total sample was enrolled, it was 
estimated that a maximum total sample size of 
1,564 (782 per group) was needed to detect a 7% 
difference in return rates (60% vs. 67%) with a two-
sided test statistic, a significance level of 0.05, and 
80% power. Study enrollment began November 7, 
2011 and was suspended when the enrollment tar-
get (N = 792) was surpassed (N = 804) on February 
29, 2016. Descriptive statistics are provided for 
patient characteristics, and return rates are com-
pared between groups using chi-square tests. 
A multivariable log-binomial model was estimated 
to examine the combined association of patient 
characteristics with return rates, while accounting 
Fig 2 | FIT-SMI contents, small-media CRC screening trial.
Table 1 | Demographic and survey characteristics of participants, small-media colorectal cancer screening trial, all sites, 2011–2016, 
n = 804
Characteristics
Total sample Control group Intervention group
p valueN (%) N (%) N (%)
Overall 804 100.0% 385 47.9% 419 52.1% —
Race
 African-American 672 85.4% 322 85.0% 350 85.8% 0.7437
 Caucasian 115 14.6% 57 15.0% 58 14.2%
Ethnicity
 Hispanic 12 1.5% 5 1.3% 7 1.7% 0.6639
 Non-Hispanic 792 98.5% 380 98.7% 412 98.3%
Age
 49–54 318 39.6% 150 39.1% 168 40.1% 0.6941
 55–59 239 29.8% 115 29.9% 124 29.6%
 60–64 152 18.9% 69 18.0% 83 19.8%
 65–69 71 8.8% 36 9.4% 35 8.4%
 70–74 23 2.9% 14 3.6% 9 2.1%
Gender
 Male 341 42.4% 159 41.3% 182 43.4% 0.5400
 Female 463 57.6% 226 58.7% 237 56.6%
Marital status
 Married 197 24.6% 94 24.5% 103 24.6% 0.9897
Not married 605 75.4% 289 75.5% 316 75.4%
Education level
<High school 253 31.5% 116 30.1% 137 32.9% 0.2260
High school grad 372 46.4% 174 45.2% 198 47.5%
Any college 177 22.1% 95 24.7% 82 19.7%
Health insurance
 None 300 37.4% 133 34.6% 167 39.9% 0.2671
 Private 104 13.0% 51 13.3% 53 12.6%
 Medicare 102 12.7% 56 14.6% 46 11.0%
 Medicaid 118 14.7% 64 16.7% 54 12.9%
 Medicare+Medicaid 50 6.2% 21 5.5% 29 6.9%
 Other 129 16.1% 59 15.4% 70 16.7%
Annual household income
 <$5,000 137 18.7% 64 18.1% 73 19.3% 0.3621
 $5,000–$14,999 260 35.6% 126 35.7% 134 35.4%
 $15,000–$24,999 226 30.9% 119 33.7% 107 28.3%
 $25,000–$34,999 62 8.5% 25 7.1% 37 9.8%
 >$35,000 46 6.3% 19 5.4% 27 7.1%
Employment status
 Employed 256 31.9% 114 29.6% 142 34.0% 0.1852
Not employed 547 68.1% 271 70.4% 276 66.0%
Year of enrollment
 2011 10 1.2% 4 1.0% 6 1.4% 0.0123
 2012 142 17.7% 66 17.1% 76 18.1%
 2013 24 3.0% 16 4.2% 8 1.9%
 2014 341 42.4% 157 40.8% 184 43.9%
 2015 256 31.8% 135 35.1% 121 28.9%
 2016 31 3.9% 7 1.8% 24 5.7%
Regular source of care
 Yes 699 87.5% 331 86.6% 368 88.2% 0.4947
 No 100 12.5% 51 13.4% 49 11.8%
(Continued )
for correlation within site. Relative risks, along with 
95% confidence intervals are reported. All analyses 




Overall, a significant difference between interven-
tion and control groups was observed only for the 
year of enrollment (p  =  .01); no significant differ-
ences were found for other participant character-
istics of race, ethnicity, age, gender, marital status, 
education level, annual household income, employ-
ment status, and enrollment site (Table 1).
Intervention outcome: return rates
Overall, 39.6% of study participants (N  =  318) 
returned the FIT. The return rate did not differ 
between the intervention (FIT-SMI) and control 
group (FIT) (39.1% vs. 40.0%, p = .8) (Table 2). For 
the entire cohort, no differences in return rates were 
observed by participant characteristics of: age, race, 
marital status, education level, annual household 
outcome, employment status, and year of enroll-
ment. Significant differences in return rates were 
observed based on health insurance coverage and 
type (p = .01) with a significantly higher rate among 
participants with no insurance compared with those 
with any insurance (p = .01). Participants with a reg-
ular source of care had significantly higher return 
rates than those who did not (41.2% vs. 29%, p = .02). 
Within the control group, significantly higher return 
rates were seen for AA versus Caucasian partici-
pants (42.9% vs. 24.6%, p  =  .01) and among those 
with health insurance compared with those without 
health insurance (p = .01). In the intervention group, 
no significant differences were observed in test 
return based on patient characteristics. Among AA 
participants, there was no difference in test return 
rate between the intervention and control group 
(p =  .26); however, the observed difference in test 
return in the Caucasian group (39.7% in the inter-
vention group, compared with 24.6% in the control 
group) approached significance at p = .08.
Factors associated with return rates
In a multivariable model controlling for all covari-
ates, gender, insurance type, and regular place for 
healthcare were significantly associated with return 
rates (Table 3). Females were more likely to return 
the kit than males (RR = 1.17, p = .03). Patients with 
private, Medicaid, or Medicare and Medicaid insur-
ance were all significantly more likely to return their 
kits compared with patients with no insurance (all p 
< .02). Patients with Medicare or Other insurance 
did not have significantly different return rates com-
pared with those with no insurance. Participants who 
had a regular place for healthcare were more likely 
to return their FIT compared with those without a 
regular place for healthcare (RR = 1.22, p = 0.01).
DISCUSSION
This study examined the use of a participant 
designed, FIT-SMI as a means of improving partic-
ipation in CRC screening among a population of 
predominantly AA patients seen in primary care 
clinics. In our prior study, we found that a large 
percentage of patients were not up-to-date on CRC 
screening and preferred an alternative to the usual 
recommendation of their clinicians for CRC screen-
ing via colonoscopy (P. Godley, unpublished, July 
20, 2010). Patients in subsequent focus groups indi-
cated their preference for a test that was not inva-
sive and/or likely to result in complications, did not 
require time away from work or for another person 
to accompany them for an inpatient procedure, did 
not require a change in diet or a “cleanse” prior to 
the test, and was less expensive.
We found that a home-based stool test was widely 
accepted by eligible patient participants who were 
at average risk for CRC and not up-to-date on CRC 
screening. Eighty-eight percent of eligible indi-
viduals (n  =  914) agreed to participate (n  =  804), 
although FIT was the only CRC screening option 
available through the study. Participant acceptance 
of the FIT screening test may have been more in line 
with their stated preferences than other screening 
modalities [22] and may have presented fewer bar-
riers to participation such as time away from work, 
the need for another person to accompany them to 
Characteristics
Total sample Control group Intervention group
p valueN (%) N (%) N (%)
Enrollment site
Clinic 1 5 0.6% 3 0.8% 2 0.5%
Clinic 2 80 10.0% 36 9.4% 44 10.5%
Clinic 3 41 5.1% 21 5.5% 20 4.8%
Clinic 4 223 27.7% 112 29.1% 111 26.5%
Clinic 5 433 53.9% 204 53.0% 229 54.7%
Clinic 6 22 2.7% 9 2.3% 13 3.1%













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































a colonoscopy, and higher relative cost of other tests 
compared with the FIT.
Although our hypothesis that participants in the 
FIT-SMI intervention group would be significantly 
more likely to return the kit than participants in the 
control group was found to be null, we did observe 
other findings that could inform both additional 
research and program development. Specifically, 
the SMI may have helped some participants use 
the kit with greater ease due to the packaging that 
included health messages, illustrated instructions 
written at fifth grade level, and larger fonts. The 
provision of free FIT tests and the guarantee of fol-
low-on screening and treatment may have removed 
structural barriers related to financial and insur-
ance coverage for some participants. Overall, when 
offered, participants accepted FIT and returned it 
40% of the time, a rate that is on the high end of 
those observed for return of home-based stool sam-
ple tests in other populations/studies [4]. Females 
and individuals with insurance and individuals with 
a regular source of care were significantly more 
likely to return the FIT.
The applicability and generalizability of these find-
ings are limited by several factors. The study enroll-
ment period spanned 52 months and was much longer 
than planned, due in part to changes within participat-
ing healthcare organizations. Specifically, one health 
system closed during the study and another with 
several clinic sites in North Carolina initiated a pro-
vider awareness campaign in 2008–2010 regarding 
compliance with the Affordable Care Act requiring 
provision of cancer screening in line with USPSTF 
recommendations. This activity included making sure 
that age-eligible patients were screened for CRC. It is 
our understanding that the campaign did not directly 
address shared decision-making and CRC screening. 
A  higher percentage of patients approached during 
this study reported being up-to-date on screening than 
patients participating in the pilot phase conducted in 
2008–2010 (P. Godley, unpublished, July 20, 2010). 
This prolonged enrollment period may have resulted 
in more variation in participating healthcare systems 
and community responses to CRC screening and 
its benefits and/or temporal changes in sub-group 
characteristics and/or response to the intervention. 
Fortunately, the USPSTF recommendations remained 
the same during the study period, thus reducing the 
possibility of bias associated with any change in rec-
ommendations over the life of this study.
The initial study population was limited to AA indi-
viduals seeking care at primary care clinics in the study 
Table 3 | Relative risk and 95% confidence intervals of the difference in return rates of small-media colorectal cancer screening trial: overall 
and by patient characteristics, n = 804 (Multivariable Model)
Characteristics Relative risk 95% CI p value
Group
Intervention vs. control 0.96 (0.79,1.16) 0.66
Age
Each 5 year increase 1.05 (0.96,1.14) 0.28
Race
African-American vs. Caucasian 1.11 (0.86, 1.43) 0.42
Gender
Female vs. male 1.17 (1.01,1.36) 0.03
Marital status
Married vs. not married 0.85 (0.69,1.04) 0.11
Education level
≥High school vs. <high school 0.98 (0.78,1.23) 0.86
Health insurance
Private vs. none 0.86 (0.77,0.96) 0.01
Medicare vs. none 1.03 (0.94,1.12) 0.55
Medicaid vs. none 0.80 (0.66,0.97) 0.02
Medicare + Medicaid vs. none 0.37 (0.18.0.73) 0.01
Other vs. none 0.83 (0.61,1.14) 0.25
Annual household income
>$35,000 vs. <$35,000 0.91 (0.69,1.21) 0.51
Employment status
Employed vs. unemployed 0.92 (0.71,1.20) 0.54
Regular place for healthcare
Yes vs. No 1.22 (1.05,1.41) 0.01
Year of enrollment
Each 1 year increase 0.93 (0.84,1.03) 0.15
area, presenting with no symptoms of CRC, at aver-
age risk of CRC, and not up-to-date on CRC screen-
ing. Although enrollment criteria were expanded to 
improve accrual by including eligible non-AA par-
ticipants later in the study (month 23), the resulting 
sample is not representative of the general population 
of all healthcare patients in the regions served by these 
clinics, the broader community of individuals in need 
of CRC screening, or any other group experiencing a 
disparity in either CRC screening or CRC mortality or 
morbidity, including the AA population.
The FIT was the only recommended screening 
modality offered to study participants, a condition 
that may have biased participants in both the inter-
vention and control arms in the direction of accept-
ing and returning the test. Acceptance may have 
also been biased given the guarantee of referral of 
any participant, if needed, to available financial 
assistance associated with the participant’s screen-
ing and other healthcare and to follow-on colonos-
copy and treatment regardless of the ability to pay at 
each participating site. At a minimum, this provision 
removed a frequently cited structural barrier (e.g., 
cost of screening) to participation in CRC screening 
and any needed follow-on treatment.
The SMI was designed to meet expressed needs 
and characteristics of the AA population but not of 
other participants in either this study or the broader 
community. Although this design potentially could 
have biased the utility of the intervention for non-AA 
populations and/or participants with higher edu-
cational levels, we found the opposite. Within the 
Caucasian group, the return rate difference between 
intervention and control groups approached signifi-
cance (p = .08) whereas no difference was observed 
for the AA group (p = .26). This finding should be 
explored in future studies that consider more care-
fully the impact of cultural context, participant moti-
vation, health literacy, and other social determinants 
in message and material development.
CONCLUSIONS
We found that a home-based stool test was widely 
accepted by a predominantly AA patient popula-
tion in collaborating primary care clinics who were 
at average risk for and not up-to-date on CRC screen-
ing. The FIT-SMI did not independently increase 
return rates, but it might have made the tests easier 
to use due to its larger font, colorful graphics, step-
by-step instructions, and health messaging. Going 
forward, refining and implementing small media 
in combination with other proven approaches such 
as the use of patient navigators/community health 
educators along with a choice of screening strate-
gies, such as newly developed more sensitive and 
specific and easier to use stool tests, could reduce 
participant burden to participate in CRC screening, 
a screening with substantial net benefit among aver-
age risk, asymptomatic adults aged 50 to 75 years. 
This benefit could be especially important for 
groups facing ongoing disparities in care such as AA 
and/or lower income, uninsured individuals.
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